Paratek files for IPO

Paratek Pharmaceuticals Inc. (Boston, Mass.) proposed to raise up to $92 million in an IPO underwritten by UBS and Leerink. Paratek plans to start two Phase III trials in 1Q13 for omadacycline to trea...